Results for this period
Third quarter1 January 2026 to 30 September 2026ConsolidatedU.S. GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in US dollar).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Operating revenue increased due to a change in the estimate used to measure progress toward satisfying the service performance obligation and the longer service period. Research and development and patent costs decreased due to lower research expenses related to MN-166, while general and administrative expenses increased due to higher professional fees and share-based compensation expenses. Interest income decreased due to lower cash balances.
There are no applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | U.S. GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026 to 30 September 2026 |
| Net Sales | 783,978 US dollar (YoY +204.0%) |
| Operating profit | -8,437,219 US dollar |
| Ordinary income | -7,743,359 US dollar |
| Profit attributable to owners of the parent | -7,743,359 US dollar |
| Net income per share | -¥25 |
| Equity ratio | End of the current fiscal period 90.8 / End of previous period 91.2 |
| Total assets | 45,242,293 US dollar |
| Net assets | 41,094,498 US dollar |
| Cash flows from operating activities | -7,775,699 US dollar |
| Cash flows from investing activities | -10,825 US dollar |
| Cash flows from financing activities | 6,235,819 US dollar |
| Cash and cash equivalents at end of period | 29,256,294 US dollar |
| Annual Dividend Forecast | 0 US dollar → 0 US dollar（0.0%） |
| Depreciation and amortization | 12,699 US dollar |
| Disclosure regarding the going concern assumption | There are no applicable matters. |
| Issued Shares at Period-End | 51,232,668 |
| Treasury Shares at Period-End | 0 |
| Factors Behind Changes in Business Performance | Operating revenue increased due to a change in the estimate used to measure progress toward satisfying the service performance obligation and the longer service period. Research and development and patent costs decreased due to lower research expenses related to MN-166, while general and administrative expenses increased due to higher professional fees and share-based compensation expenses. Interest income decreased due to lower cash balances. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The increase in operating revenue was attributable to a change in the estimate used to measure progress toward satisfying the performance obligation under the agreement with the Mayo Foundation, as well as the service period in 2026 being one quarter longer than in 2025. The decrease in research and development and patent costs was primarily due to lower research expenses related to MN-166. The increase in general and administrative expenses was primarily due to higher professional fees and share-based compensation expenses. The decrease in interest income was primarily due to lower interest-bearing cash balances.